Department of Chemical and Petroleum Engineering, Sharif University of Technology, Tehran, Iran.
Department of Chemical and Petroleum Engineering, Sharif University of Technology, Tehran, Iran.
Int J Biol Macromol. 2024 Apr;263(Pt 1):129685. doi: 10.1016/j.ijbiomac.2024.129685. Epub 2024 Feb 22.
Microfluidic systems are capable of producing microgels with a monodisperse size distribution and a spherical shape due to their laminar flow and superior flow. A significant challenge in producing these drug-carrying microgels is simultaneous drug loading into microgels. Various factors such as the type of polymer, the type of drug, the volume ratio of the drug to the polymer, and the geometry of the microfluidic system used to generate microgels can effectively address these challenges. The overall goal of this study was to produce mono-disperse drug-carrying microgels capable of controlled drug release. To achieve this goal, this study used a stream-focused microfluidic chip containing a coating current to prevent chip clogging. Alginate oxide was synthesized with a 30 % oxidation percentage. Alginate oxide, gelatin, and compositions of them with volume ratios of 50-50, 70-30, and 30-70, by determining their appropriate weight percentage, were used for the controlled release of letrozole. The properties of the produced microgels were measured through various tests such as drug release test, loading percentage, SEM, FTIR, swelling ratio, and dimensional stability. It was found that microgels made of a combination of alginate oxide-gelatin with volume ratios of 70-30 had a good swelling ratio and structural stability. The drug loading percentages for alginate, alginate oxide, and alginate oxide-gelatin with volume ratios of 50-50 and 30-70, respectively, were 56 %, 68 %, and 66 %, 61 % and the alginate oxide-gelatin with a volume ratio of 70-30 compared to other samples had over 70 % drug loading percentages. Furthermore, samples of alginate, alginate oxide, and alginate oxide-gelatin with volume ratios of 50-50 and 30-70 had 94 %, 63 %, 56 %, and 68 % drug release in 13 days, respectively. However, alginate oxide-gelatin with a volume ratio of 70-30 had a release rate of about 50 % in 13 days, which is a more controlled release for letrozole compared to the volume ratios of 50-50 and 30-70. Examining the drug release profile, it was concluded that drug release follows the Higuchi model and therefore follows Fick's first law of diffusion. It can be concluded that the combination of alginate oxide-gelatin produces more suitable microgels than alginate and alginate oxide for the controlled-release of letrozole. A comparison of microgels of alginate oxide and gelatin with volume ratios of 50-50 and 70-30 had better results for the cytotoxicity study compared to other samples.
微流控系统能够由于其层流和优越的流动而产生具有单分散尺寸分布和球形的微凝胶。生产这些载药微凝胶的一个主要挑战是将药物同时载入微凝胶中。聚合物的类型、药物的类型、药物与聚合物的体积比以及用于生成微凝胶的微流控系统的几何形状等各种因素可以有效地解决这些挑战。本研究的总体目标是生产能够控制药物释放的单分散载药微凝胶。为了实现这一目标,本研究使用了一种含有涂层电流的聚焦流微流控芯片来防止芯片堵塞。氧化海藻酸钠的氧化度为 30%。通过确定适当的重量百分比,使用氧化海藻酸钠、明胶以及它们的体积比为 50-50、70-30 和 30-70 的组合,来进行来曲唑的控制释放。通过药物释放试验、载药量、SEM、FTIR、溶胀比和尺寸稳定性等各种测试来测量所生产的微凝胶的性质。结果发现,体积比为 70-30 的氧化海藻酸钠-明胶微凝胶具有良好的溶胀比和结构稳定性。海藻酸钠、氧化海藻酸钠和体积比为 50-50 和 30-70 的氧化海藻酸钠-明胶的载药量分别为 56%、68%和 66%、61%,而体积比为 70-30 的氧化海藻酸钠-明胶的载药量超过了其他样品的 70%。此外,体积比为 50-50 和 30-70 的海藻酸钠、氧化海藻酸钠和氧化海藻酸钠-明胶的样品在 13 天内分别释放了 94%、63%、56%和 68%的药物,但体积比为 70-30 的氧化海藻酸钠-明胶在 13 天内的释放率约为 50%,这是来曲唑的更受控释放,与体积比为 50-50 和 30-70 的相比。通过考察药物释放曲线,可以得出药物释放遵循 Higuchi 模型,因此遵循 Fick 的第一扩散定律。可以得出结论,氧化海藻酸钠-明胶的组合比海藻酸钠和氧化海藻酸钠更适合来曲唑的控释。与其他样品相比,体积比为 50-50 和 70-30 的氧化海藻酸钠和明胶的微凝胶在细胞毒性研究中具有更好的结果。